176 related articles for article (PubMed ID: 10698513)
21. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.
Fujii GH; Morimoto AM; Berson AE; Bolen JB
Oncogene; 1999 Mar; 18(9):1765-9. PubMed ID: 10208437
[TBL] [Abstract][Full Text] [Related]
22. The biology and clinical relevance of the PTEN tumor suppressor pathway.
Sansal I; Sellers WR
J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice.
You MJ; Castrillon DH; Bastian BC; O'Hagan RC; Bosenberg MW; Parsons R; Chin L; DePinho RA
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1455-60. PubMed ID: 11818530
[TBL] [Abstract][Full Text] [Related]
25. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cheney IW; Johnson DE; Vaillancourt MT; Avanzini J; Morimoto A; Demers GW; Wills KN; Shabram PW; Bolen JB; Tavtigian SV; Bookstein R
Cancer Res; 1998 Jun; 58(11):2331-4. PubMed ID: 9622068
[TBL] [Abstract][Full Text] [Related]
26. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.
Vasudevan KM; Burikhanov R; Goswami A; Rangnekar VM
Cancer Res; 2007 Nov; 67(21):10343-50. PubMed ID: 17974977
[TBL] [Abstract][Full Text] [Related]
27. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB
Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942
[TBL] [Abstract][Full Text] [Related]
28. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers.
Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M
Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903
[TBL] [Abstract][Full Text] [Related]
29. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
[TBL] [Abstract][Full Text] [Related]
30. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
[TBL] [Abstract][Full Text] [Related]
31. [Biology of endometrial cancer].
Fujita M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():264-8. PubMed ID: 15535248
[No Abstract] [Full Text] [Related]
32. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
Matsushima-Nishiu M; Unoki M; Ono K; Tsunoda T; Minaguchi T; Kuramoto H; Nishida M; Satoh T; Tanaka T; Nakamura Y
Cancer Res; 2001 May; 61(9):3741-9. PubMed ID: 11325847
[TBL] [Abstract][Full Text] [Related]
33. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
[TBL] [Abstract][Full Text] [Related]
34. [Cowden disease].
Sawada T; Hamano N; Suzuki A; Okada T; Mabuchi H
Nihon Rinsho; 2000 Jul; 58(7):1479-83. PubMed ID: 10921327
[TBL] [Abstract][Full Text] [Related]
35. [PTEN: a tumor suppressor with original properties].
Roux P
Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424
[TBL] [Abstract][Full Text] [Related]
36. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas.
Zhang P; Steinberg BM
Cancer Res; 2000 Mar; 60(5):1457-62. PubMed ID: 10728713
[TBL] [Abstract][Full Text] [Related]
38. Anticorresponding mutations of the KRAS and PTEN genes in human endometrial cancer.
Ikeda T; Yoshinaga K; Suzuki A; Sakurada A; Ohmori H; Horii A
Oncol Rep; 2000; 7(3):567-70. PubMed ID: 10767369
[TBL] [Abstract][Full Text] [Related]
39. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
[TBL] [Abstract][Full Text] [Related]
40. Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia.
Sun H; Enomoto T; Shroyer KR; Ozaki K; Fujita M; Ueda Y; Nakashima R; Kuragaki C; Ueda G; Murata Y
Diagn Mol Pathol; 2002 Dec; 11(4):204-11. PubMed ID: 12459636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
